Susquehanna International Group’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-41,014
Closed -$244K 6380
2025
Q1
$244K Buy
+41,014
New +$244K ﹤0.01% 5293
2024
Q3
Sell
-14,455
Closed -$123K 5629
2024
Q2
$123K Buy
14,455
+13,649
+1,693% +$116K ﹤0.01% 5020
2024
Q1
$14K Sell
806
-2,691
-77% -$46.7K ﹤0.01% 5334
2023
Q4
$44.8K Sell
3,497
-5,057
-59% -$64.8K ﹤0.01% 5561
2023
Q3
$316K Buy
8,554
+2,268
+36% +$83.9K ﹤0.01% 3977
2023
Q2
$253K Sell
6,286
-2,582
-29% -$104K ﹤0.01% 4408
2023
Q1
$643K Buy
8,868
+6,584
+288% +$477K ﹤0.01% 3500
2022
Q4
$187K Sell
2,284
-6,749
-75% -$553K ﹤0.01% 4541
2022
Q3
$854K Buy
9,033
+6,678
+284% +$631K ﹤0.01% 2756
2022
Q2
$458K Sell
2,355
-2,336
-50% -$454K ﹤0.01% 3463
2022
Q1
$1.09M Sell
4,691
-385
-8% -$89.4K ﹤0.01% 2699
2021
Q4
$2M Buy
5,076
+925
+22% +$364K ﹤0.01% 1974
2021
Q3
$1.86M Buy
4,151
+1,204
+41% +$539K ﹤0.01% 2045
2021
Q2
$1.15M Buy
2,947
+534
+22% +$208K ﹤0.01% 2798
2021
Q1
$866K Buy
2,413
+169
+8% +$60.7K ﹤0.01% 3165
2020
Q4
$1.1M Buy
2,244
+636
+40% +$312K ﹤0.01% 2467
2020
Q3
$521K Buy
1,608
+239
+17% +$77.4K ﹤0.01% 2964
2020
Q2
$498K Buy
1,369
+95
+7% +$34.6K ﹤0.01% 2928
2020
Q1
$271K Buy
1,274
+339
+36% +$72.1K ﹤0.01% 3521
2019
Q4
$385K Sell
935
-1,473
-61% -$607K ﹤0.01% 2912
2019
Q3
$850K Sell
2,408
-965
-29% -$341K ﹤0.01% 2222
2019
Q2
$1.7M Buy
+3,373
New +$1.7M ﹤0.01% 1440
2019
Q1
Hold
0
3058
2018
Q4
Hold
0
3668
2018
Q3
Sell
-1,921
Closed -$1.77M 3367
2018
Q2
$1.77M Buy
+1,921
New +$1.77M ﹤0.01% 1095
2018
Q1
Hold
0
3386
2017
Q4
Hold
0
3670
2017
Q3
Hold
0
3171
2017
Q2
Hold
0
3529
2017
Q1
Sell
-737
Closed -$261K 3273
2016
Q4
$261K Buy
+737
New +$261K ﹤0.01% 3525
2016
Q1
Hold
0
3840
2015
Q4
Sell
-968
Closed -$761K 4219
2015
Q3
$761K Buy
+968
New +$761K ﹤0.01% 2709
2015
Q2
Hold
0
4450
2015
Q1
Sell
-368
Closed -$246K 4086
2014
Q4
$246K Buy
+368
New +$246K ﹤0.01% 3881